SEAS ADR Distinguished Seminar Series II
Role of Nuclear Hormone Receptors in Regulation of Lipid and Bile Acid Metabolism, Mitochondrial Function, Inflammation and FibrosisJoin SEAS ADR for the second in their Distinguished Seminar Series with a presentation, Role of Nuclear Hormone Receptors in Regulation of Lipid and Bile Acid Metabolism, Mitochondrial Function, Inflammation and Fibrosis by Dr. Moshe Levi, Georgetown University Medical Center.
Bio
Moshe joined Georgetown University Medical Center (GUMC) in October 2017 as Professor of Biochemistry and Molecular & Cellular Biology. In October 2019 he was named the Interim Dean for Research and in October 2022 as the Chief Scientific Officer for Research and Development. Moshe serves as the Chair of the Board of the American Physician Scientist Association (APSA), and he is President of the Kern Lipid Organization. In 2013, he was appointed a member of the Board of Scientific Counselors for the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases and recently concluded his service as its chair. Moshe is a fellow of the American Heart Association, the American Physiology Society, and the American Society of Nephrology.
Moshe’s research involves renal, hepatic, and cardiovascular complications of obesity, diabetes, and aging; the role of obesity, diabetes, and aging in COVID-19-induced complications; regulation of mineral metabolism; and applying new label-free techniques for imaging lipids, inflammation, oxidative stress, metabolism, and fibrosis. He has co-authored 200 manuscripts and nearly 40 book chapters and has mentored over 36 MD or Ph.D. research trainees.